Whan In Pharm Co.,Ltd.

KRX:016580.KS

13310 (KRW) • At close September 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) KRW.

20232022202120202019201820172016201520142013201220112010200920082007
Operating Activities:
Net Income 29,774.32223,733.58726,458.50623,191.29818,611.97721,517.95927,172.31116,397.45520,509.66118,805.53514,580.14915,796.56314,612.07717,236.90814,434.5511,154.23711,275.625
Depreciation & Amortization 6,640.4764,846.7544,201.9714,069.8313,900.0292,825.0852,286.7082,021.2481,916.9891,890.2791,716.0721,471.5211,237.0482,438.1042,046.1772,152.9742,201.786
Deferred Income Tax 00000000000000000
Stock Based Compensation 00000000000000000
Change In Working Capital -15,824.208-12,806.5493,875.943-5,186.4171,789.571-5,972.242-3,155.25-1,751.252-6,597.119-9,556.197-6,121.7244,858.451-3,987.859-4,890.8391,632.984-10,334.458-4,644.655
Accounts Receivables -7,319.845-10,221.037-56.458-93.6373,496.865670.204-5,290.8112,694.664-4,571.6200000000
Inventory -17,631.056-3,893.12811.935-5,139.876-2,413.753-4,998.3-808.581-163.606-1,521.189-3,217.494-1,496.711-2,222.3781,569.747-2,187.54835.762-4,642.471-501.819
Accounts Payables 9,255.0592,409.3423,554.562-228.807182.345-977.8922,623.304-3,854.6283,592.98400000000
Other Working Capital -128.366-1,101.727365.904275.904524.115-973.942-2,346.668-1,587.646-5,075.931-6,338.703-4,625.0137,080.829-5,557.605-2,703.2911,597.222-5,691.987-4,142.836
Other Non Cash Items 2,606.1921,077.382781.525679.971429.374-915.993-2,823.933,156.59297.6912,270.765492.26-1,015.3113,254.034-245.187493.497121.279746.231
Operating Cash Flow 23,196.78216,851.17435,317.94522,754.68324,730.95117,454.8123,479.83919,824.04315,927.22213,410.38210,666.75721,111.22415,115.314,538.98618,607.2083,094.0329,578.987
Investing Activities:
Investments In Property Plant And Equipment -31,489.003-67,758.978-4,762.017-8,223.602-3,015.158-4,591.609-19,313.296-7,462.278-3,349.951-11,938.044-1,229.859-5,063.327-3,458.245-1,774.379-2,379.218-1,807.357-835.576
Acquisitions Net 259.373-300-750-1,2306.722490.314-178.976885.941-435.5591,727.352-59.4561.358-769.204-33.842-192.959-7.4914.192
Purchases Of Investments -83,086.053-145,291.141-256,271.619-274,514.017-213,869.655-127,219.442-84,803.76-33,644.422-24,321.821-58,999.834-19,566.887-14,125.2-14,650.038-25,755.244-13,763.055-33,661-25,926.813
Sales Maturities Of Investments 104,861.401175,079.868259,430.778284,588.962176,165.605116,410.50665,687.38533,924.2926,619.52451,678.8688,268.39618,606.9918,416.9115,617.96719,655.01532,925.52414,018.515
Other Investing Activites 22.613-671.749230.424-17.92590.486602.4721,126.876-551.382940.133-35.754-65.091117.684-260.535-1,189.156-1,394.508-70.512-705.219
Investing Cash Flow -9,431.669-38,942-2,122.434603.422-40,122-14,307.757-37,481.772-6,847.851-547.675-17,567.412-12,652.897-462.495-721.111-23,134.6541,925.275-2,620.835-13,434.901
Financing Activities:
Debt Repayment 00000000000000000
Common Stock Issued 0000000000004,262.4570005,270.685
Common Stock Repurchased 00000000000000-3,981.6720-7,339.714
Dividends Paid -4,580.121-4,580.121-4,580.121-4,580.121-4,580.121-4,580.121-3,816.768-3,816.768-3,816.768-3,816.768-3,816.768-3,816.768-3,641.768-3,641.768-3,033.414-3,033.414-3,053.414
Other Financing Activities -585.903-549.983-613.78-607.139-583.17000000.00100.00184.6640-40.042-40.717
Financing Cash Flow -5,166.024-5,130.104-5,193.901-5,187.26-5,163.291-4,580.121-3,816.768-3,816.768-3,816.768-3,816.768-3,816.768-3,816.768620.689-3,557.104-7,015.086-3,073.456-5,163.16
Other Information:
Effect Of Forex Changes On Cash -8.578-59.269-19.766-78.723.70318.103-23.992.133-0.06000-000.00200
Net Change In Cash 8,590.511-27,280.19927,981.84418,092.145-20,530.637-1,414.966-17,842.6899,161.55711,562.72-7,973.797-5,802.90716,831.96115,014.878-12,152.77213,517.399-2,600.259-9,019.074
Cash At End Of Period 45,366.2136,775.69964,055.89736,074.05317,981.90938,512.54639,927.51157,770.248,608.64337,045.92345,019.7250,822.62833,990.66619,060.45231,213.22417,695.82520,296.084